Biogen Inc at Sanford C Bernstein Strategic Decisions Conference Transcript
Let's go ahead and start. We're very fortunate to have with us today the team from Biogen, CEO, Michel Vounatsos; and Head of R&D, Michael Ehlers.
So what we're going to do is, they're both going to say a few words as an introduction and then we'll have a fireside chat. You all have the cards in front of you. Should you want to ask question, you have the choice in the end of just raising the card and then someone will pick it up and pass it to me, or if you want to ask, just get up and ask your questions or raise your hand and I'll point to you and you ask the question that way.
Before we start, I know that it's Biogen. There's been some misunderstanding about what happened with Allergan who was supposed to be here at 9:00 a.m., and it appears that they will cancel. They didn't cancel. They're going to participate at 4:00 p.m. The entire issue was that the CEO had some conflict in the morning, and they asked if we can -- if they can have the presentation in the afternoon. They'll be here in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
